Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[European Acute Transfusion Hepatitis Interferon Study (EATHIS)].

A M Jullien1, A M Dejean, C Janot

  • 1Centre National de Transfusion Sanguine, Hôpital Saint-Antoine, Paris.

Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Immunohematologic follow-up and transfusion safety in hematopoietic stem cells allografts].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2003
Same author

Declared hepatitis C screening strategies in blood recipients in French hospitals.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2002
Same author

Plateletpheresis concentrates produced with the COMTEC cell separator: the French experience.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2002
Same author

The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system.

Haemophilia : the official journal of the World Federation of Hemophilia·2001
Same author

Prevalence of GBV C/HGV RNA and GBV C/HGV antibodies in French volunteer blood donors: results of a collaborative study.

Vox sanguinis·1999
Same author

A novel vector for the study of hepatitis delta virus replication.

Journal of virological methods·1998

The European Acute Transfusion Hepatitis Interferon Study (EATHIS) found a reduced incidence of non-A, non-B post-transfusion hepatitis (PTH), with a mean of 1% from 1989-1991. This highlights the importance of transfusion vigilance programs for monitoring hepatitis risk.

Area of Science:

  • Hepatology
  • Transfusion Medicine
  • Infectious Diseases

Background:

  • Post-transfusion hepatitis (PTH) poses a significant risk to recipients.
  • The European Acute Transfusion Hepatitis Interferon Study (EATHIS) was initiated to investigate PTH incidence.
  • Collaborative efforts involving multiple blood centers are crucial for large-scale epidemiological studies.

Purpose of the Study:

  • To determine the incidence of non-A, non-B post-transfusion hepatitis (PTH).
  • To evaluate the effectiveness of transfusion vigilance programs.
  • To assess the role of interferon in managing transfusion-related hepatitis.

Main Methods:

  • Prospective, multicentric study involving 16 French blood centers.
  • Follow-up of 1,011 transfused recipients for at least four months.

Related Experiment Videos

  • Monitoring of transaminases and viral markers in recipients.

    • Main Results:

    • The incidence of non-A, non-B PTH varied from 0.1% to 6% across locations.
    • A mean PTH incidence of 1% was observed for the period 1989-1991.
    • Out of 15 hepatitis cases, 10 were confirmed as post-transfusional.

    Conclusions:

    • Preliminary data suggest a reduced incidence of PTH.
    • Transfusion vigilance programs, including recipient follow-up and testing, are vital.
    • Continued monitoring and research are essential for mitigating transfusion-transmitted infections.